Evidence map›Paper›PMID 40776831›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2026

Serum Cytokine Profiling Differentiates Underlying Diseases in Cytokine Storm Syndrome.

Shuya Kaneko, Maho Hatano, Asami Shimbo, Futaba Miyaoka, Hitoshi Irabu, Yuko Akutsu, Yuko Hayashi, Mao Mizuta, Yasuo Nakagishi, Keiji Akamine and 33 more

Abstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors.

Shuya KanekoDepartment of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-8840-5373
Maho HatanoDepartment of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
Asami ShimboDepartment of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
Futaba MiyaokaDepartment of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
Hitoshi IrabuDepartment of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
Yuko AkutsuDepartment of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
Yuko HayashiDepartment of Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
Mao MizutaDepartment of Pediatric Rheumatology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
Yasuo NakagishiDepartment of Pediatric Rheumatology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
Keiji AkamineDepartment of Nephrology and Rheumatology, Tokyo Metropolitan Children's Medical Center, Fuchu, Japan.
Naomi IwataDepartment of Immunology and Infectious Diseases, Aichi Children's Health and Medical Center, Obu, Japan.
Kenji Furuno(current address: Department of Pediatrics, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan): Department of General Pediatrics and Interdisciplinary Medicine, Fukuoka Children's Hospital, Fukuoka, Japan.
Takayuki TanakaDepartment of Pediatrics, Japanese Red Cross Otsu Hospital, Otsu, Japan.
Kazuyuki UenoDepartment of Pediatrics, Toyama Prefectural Central Hospital, Toyama, Japan.
Shuhei FujitaDepartment of Pediatrics, Toyama Prefectural Central Hospital, Toyama, Japan.
Koji YokoyamaDepartment of Pediatrics, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
Toshinori MinatoDepartment of Pediatrics, Toyooka Hospital, Toyooka, Japan.
Kazushi IzawaDepartment of Pediatrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID https://orcid.org/0000-0003-1080-0936
Takahiro YasumiDepartment of Pediatrics, Kyoto University Graduate School of Medicine, and Japan Environment and Children's Study Kyoto Regional Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Tadashi MatsubayashiDepartment of Pediatrics, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Tadashi HosoyaDepartment of Rheumatology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
Hiroki NishikawaDepartment of Pediatrics, Nara Prefecture General Medical Center, Nara, Japan.
Junya FujimuraDepartment of Pediatrics, Kakogawa Central City Hospital, Kakogawa, Japan.
Ryoko AsanoFirst Department of Internal Medicine, University of Toyama, Toyama, Japan.
Yuko SugitaDepartment of Pediatrics, School of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Kenichi WatanabeDepartment of Pediatrics, Japanese Red Cross Nagaoka Hospital, Nagaoka, Japan.
Anna KobayashiDepartment of Pediatrics, University of Yamanashi, Yamanashi, Japan.
Takuya EndoDepartment of Pediatrics, Saitama Medical University, Kawagoe, Japan.
Katsuhide EguchiDepartment of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Ryuta NishikomoriDepartment of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan.ORCID https://orcid.org/0000-0002-9407-6158
Ryuhei YasuokaDepartment of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Takaki AsanoDepartment of Pediatrics, Hiroshima University Graduate School of Biomedical and Health Sciences and Department of Genetics and Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Miyako KannoDepartment of Pediatrics, Yamagata University School of Medicine, Yamagata, Japan.
Kazuya HamadaDepartment of Child Health and Welfare (Pediatrics), Graduate School of Medicine, University of the Ryukyus, Nakagami-gun, Japan.
Yuji FujitaDepartment of Pediatrics, Dokkyo Medical University, Shimotsuga-gun, Japan.ORCID https://orcid.org/0000-0001-6440-9110
Daisuke HayashiDepartment of Pediatrics, Tsuchiura Kyodo General Hospital, Tsuchiura, Japan.
Shojiro WatanabeDepartment of Pediatrics, Ehime University Graduate School of Medicine, Toon, Japan.
Takeshi ShibaDepartment of Pediatrics, Tenri Hospital, Tenri, Japan.
Shinsuke YasudaDepartment of Rheumatology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0001-6171-2077
Masaaki MoriJoint Research Department of Lifelong Immunotherapy, Institute of Science Tokyo, Tokyo, Japan, and Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Hirokazu KaneganeDepartment of Child Health and Development, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
Masatoshi TakagiDepartment of Pediatrics and Developmental Biology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
Masaki ShimizuDepartment of Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0003-1077-7772

Funding

Medical and Biological Laboratories Co., Ltd.
6 · The paper itself

Abstract

objectiveCytokine storm syndrome (CSS), commonly associated with hemophagocytic lymphohistiocytosis (HLH), is a fatal hyperinflammatory syndrome. Differentiating the underlying diseases responsible for CSS is essential for timely therapeutic decisions. This study explored the clinical usefulness of serum cytokine profiling in distinguishing underlying diseases in patients with CSS.

methodsSerum samples were collected from 143 adult and pediatric patients with CSS and 22 healthy controls. The cohort included patients with various diagnoses of primary and secondary HLH and Kawasaki disease (KD)-like hyperinflammatory syndromes. Serum levels of 48 cytokines were analyzed in 97 patients using a bead-based multiplex immunoassay (Luminex assay). Serum levels of interferon alpha (IFN-α), interleukin-18 (IL-18), IL-6, CXCL9, and soluble tumor necrosis factor receptor II (sTNF-RII) were measured in 165 participants using enzyme-linked immunosorbent assay (ELISA).

resultsLuminex assay categorized patients with CSS into five clusters based on serum cytokine patterns. ELISA revealed distinct cytokine patterns, wherein patients with histiocytic necrotizing lymphadenitis-associated HLH and systemic lupus erythematosus-associated macrophage activation syndrome (MAS) showed elevated IFN-α; systemic juvenile idiopathic arthritis-associated and adult-onset Still's disease-associated MAS, X-linked inhibitor of apoptosis protein deficiency with HLH, and NLRC4-associated autoinflammatory disorder exhibited higher IL-18 levels. Additionally, KD shock syndrome had higher IL-6 levels than the other groups. CXCL9 was significantly elevated in patients with virus-associated HLH, familial HLH, malignant lymphoma-associated HLH, and KD-MAS. Multisystem inflammatory syndrome in children and toxic shock syndrome also showed moderate elevations of CXCL9 and IL-6 levels.

conclusionSerum cytokine profiling effectively differentiates CSS subtypes, facilitating better diagnosis and personalized treatment strategies based on specific disease backgrounds.

Identifiers

PMID40776831
PMCPMC12936889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.